2022
DOI: 10.3390/md20110657
|View full text |Cite
|
Sign up to set email alerts
|

Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants

Abstract: Severe acute respiratory syndrome–Coronavirus 2 (SARS-CoV-2) can infect various human organs, including the respiratory, circulatory, nervous, and gastrointestinal ones. The virus is internalized into human cells by binding to the human angiotensin-converting enzyme 2 (ACE2) receptor through its spike protein (S-glycoprotein). As S-glycoprotein is required for the attachment and entry into the human target cells, it is the primary mediator of SARS-CoV-2 infectivity. Currently, this glycoprotein has received co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 138 publications
0
9
0
Order By: Relevance
“…There is significant potential for microalgae to be engineered for improved nutritional value and to serve as novel therapeutic production platforms. The nutritional value of alga strains could conceivably be augmented via bioengineering to produce honey bee nutrient storage proteins, such as vitellogenin and royal jelly proteins. Such alga strains could more closely recapitulate the dietary amino acid requirements of bees.…”
Section: Discussionmentioning
confidence: 99%
“…There is significant potential for microalgae to be engineered for improved nutritional value and to serve as novel therapeutic production platforms. The nutritional value of alga strains could conceivably be augmented via bioengineering to produce honey bee nutrient storage proteins, such as vitellogenin and royal jelly proteins. Such alga strains could more closely recapitulate the dietary amino acid requirements of bees.…”
Section: Discussionmentioning
confidence: 99%
“…Chlamydomonas has also emerged as an organism with great biotechnological potential [ 34 ]. It is worth noting its use for the production of vaccines [ 35 ], antibodies [ 36 ], or in human clinical trials aimed to improve gastrointestinal health [ 37 ]. Furthermore, Chlamydomonas is also an excellent model for studying the basis of mutualistic interactions with bacteria, based on carbon–nitrogen exchange [ 38 ].…”
Section: Chlamydomonas Reinhardtii As a Model In Mo Homeostasismentioning
confidence: 99%
“…[ 16–20 ] Gene engineered microalgae have been tested in protein drug development [ 21 ] and edible vaccine production. [ 22–24 ]…”
Section: Introductionmentioning
confidence: 99%